About
Danjuma Quarless is a biotech investor and former computational biologist who has held investing roles in pharma-backed venture organizations. Public 2024 sources place him as Associate Director at AbbVie Ventures and on the board of Oisín Biotechnologies following AbbVie Ventures' lead investment in Oisín's Series A first close. As of a BIO International Convention 2026 speaker profile published for the June 22-25, 2026 event, he is listed as Senior Director, AI Innovation at Lilly Ventures, part of Eli Lilly and Company.
Areas of interest
biotechventure capitaldrug discoveryAI in drug developmentcomputational biologygenomicslongevity